These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18671625)

  • 1. Moyamoya.
    Scott RM
    J Neurosurg Pediatr; 2008 Aug; 2(2):158; author reply 158. PubMed ID: 18671625
    [No Abstract]   [Full Text] [Related]  

  • 2. Anesthesia for cerebral revascularization for adult moyamoya syndrome associated with sickle cell disease.
    Chong CT; Manninen PH
    J Clin Neurosci; 2011 Dec; 18(12):1709-12. PubMed ID: 21992742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on: Highlight: Is smoke the signal for surgery? Should the moyamoya syndrome "puff of smoke" trigger cerebral revascularization surgery in children with sickle cell disease?
    Aldana PR; Pederson JM; Smith ER
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30520. PubMed ID: 37376949
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
    Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
    World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter to the Editor Regarding "Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease".
    Yu J; Du Q; Chen J
    World Neurosurg; 2020 Jun; 138():582. PubMed ID: 32545006
    [No Abstract]   [Full Text] [Related]  

  • 7. Moyamoya disease.
    Menovsky T; De Ridder D
    J Neurosurg; 2007 Jun; 106(6 Suppl):517; author reply 517. PubMed ID: 17566414
    [No Abstract]   [Full Text] [Related]  

  • 8. In Reply to the Letter to the Editor Regarding "Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease".
    Terrell D; Savardekar AR; Whipple SG; Sun H
    World Neurosurg; 2020 Jun; 138():583-584. PubMed ID: 32545007
    [No Abstract]   [Full Text] [Related]  

  • 9. Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease.
    Alamri A; Hever P; Cheserem J; Gradil C; Bassi S; Tolias CM
    Br J Neurosurg; 2019 Apr; 33(2):161-164. PubMed ID: 28616936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [STA-MCA and STA-ACA anastomosis for moyamoya disease].
    Okada Y; Kawashima A; Hori T
    No Shinkei Geka; 2009 Oct; 37(10):959-71. PubMed ID: 19882956
    [No Abstract]   [Full Text] [Related]  

  • 11. Moyamoya: to cut or not to cut is not the only question. A paediatric neurologist's perspective.
    Ganesan V
    Dev Med Child Neurol; 2010 Jan; 52(1):10-3. PubMed ID: 19895633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.
    Fryer RH; Anderson RC; Chiriboga CA; Feldstein NA
    Pediatr Neurol; 2003 Aug; 29(2):124-30. PubMed ID: 14580655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute pulmonary disease in a young woman with sickle cell anemia and moyamoya disease.
    Avriel A; Fainberg U; Fuchs L; Jotkowitz A; Smoliakov A; Avnon LS; Shleyfer E
    Isr Med Assoc J; 2009 Dec; 11(12):766-8. PubMed ID: 20166350
    [No Abstract]   [Full Text] [Related]  

  • 14. Revascularization Is Associated With a Reduced Stroke Risk in Patients With Sickle Cell-Associated Moyamoya Syndrome.
    Newman S; McMahon JT; Boulter JH; Malcolm JG; Revuelta Barbero JM; Chern JJ; Barrow DL; Pradilla G
    Neurosurgery; 2022 Apr; 90(4):441-446. PubMed ID: 35132969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect revascularisation for paediatric moyamoya disease: the EDAMS technique.
    Ozgur BM; Aryan HE; Levy ML
    J Clin Neurosci; 2006 Jan; 13(1):105-8. PubMed ID: 16410206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment for moyamoya disease].
    Kaminogo M; Nagata I
    No To Shinkei; 2004 Feb; 56(2):143-52. PubMed ID: 15098359
    [No Abstract]   [Full Text] [Related]  

  • 17. [Strategy for direct anastomosis in moyamoya disease].
    Touho H
    No Shinkei Geka; 2004 Apr; 32(4):327-31. PubMed ID: 15227838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indirect anastomoses for moyamoya disease].
    Matsushima Y
    No Shinkei Geka; 1998 Sep; 26(9):769-86. PubMed ID: 9757454
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracerebral hemorrhage after prophylactic revascularization in a patient with adult moyamoya disease.
    Otawara Y; Ogasawara K; Seki K; Kibe M; Kubo Y; Ogawa A
    Surg Neurol; 2007 Sep; 68(3):335-7; discussion 337. PubMed ID: 17719983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moyamoya disease--diagnosis and treatment: indirect cerebral revascularization at the Sheba Medical Center.
    Nissim O; Bakon M; Ben Zeev B; Goshen E; Knoller N; Hadani M; Feldman Z
    Isr Med Assoc J; 2005 Oct; 7(10):661-6. PubMed ID: 16259350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.